The Neonatal Genomics Program comprises a group of clinicians and researchers with expertise in neonatal-perinatal medicine, genetics and genomics, epidemiology, health services research, and computational genomics.
Dr. Wojcik is a physician-scientist with clinical training in both neonatology and genetics and research expertise in clinical effectiveness, health services research, and genomic analysis. Her research focuses on implementing genomic medicine equitably to improve health and health-related quality of life for all infants and their families.
Dr. D’Gama is a physician-scientist with clinical expertise in neonatology and research expertise in developmental neuroscience and genetics/genomics. Her research focuses on discovering genetic mechanisms underlying human disease and advancing equitable precision medicine for infants and children with neurological and genetic conditions, especially infants with epilepsy and related neurogenetic disorders.
Dr. Morton is a physician-scientist with clinical training in neonatology and basic science expertise in developmental biology, genetics, and computational biology. Her research focuses on discovering genes and variants that explain human disease and understanding how genetic factors contribute to the long-term health of infants and children with congenital anomalies.
Dr. O’Connell is a physician-scientist with clinical training and expertise in neonatology and immunology. Her research focuses on developmental immunology as well as rare disease gene discovery.
Dr. Duyzend is a clinician-scientist with basic science expertise in genetics and genomics, sequencing technologies, and computational biology. His research focuses on understanding genetics across the developmental continuum, from conception through infancy, and the development of methods to track and analyze genetic and clinical data longitudinally through this period.
Laura Tannenbaum is a neonatal nurse practitioner in the Neonatal Intensive Care Unit (NICU) at Boston Children’s who is dedicated to advancing care for infants with rare disorders.
Tabitha Poorvu is the Genetic Counseling Program Manager in the Fetal Care and Surgery Center; she has clinical and research expertise in perinatal genetic diagnosis and complex fetal care. She has been a prenatal genetic counselor for 11 years and lead genetic counselor at the FCSC for seven years.
Malika Sud is a genetic counselor who works in the Fetal Care and Surgery Center; she has clinical and research expertise in rare disease diagnosis and perinatal outcomes. She has also been involved in several projects at the Broad Institute.
Dr. Hu is a fellow in the Harvard Neonatal Perinatal Medicine program with research expertise in epidemiologic methods used for clinical genetics and the impact of genetic diagnosis on the care of critically ill infants. Her research focuses on understanding the clinical effectiveness of diagnostic genetic evaluations in the NICU through analysis of population data.